Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy.
Zhou JC, Jin CC, Wei XL, Xu RB, Wang RY, Zhang ZM, Tang B, Yu JM, Yu JJ, Shang S, Lv XX, Hua F, Li PP, Hu ZW, Shen YM, Wang FP, Ma XY, Cui B, Geng FN, Zhang XW.
Zhou JC, et al. Among authors: li pp.
Front Pharmacol. 2023 Apr 12;14:1118017. doi: 10.3389/fphar.2023.1118017. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37124193
Free PMC article.